MeSH term
Frequency | Condition_Probility | 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) | 3 | 30.0 |
Comparative Study | 8 | 0.0 |
Humans | 23 | 0.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
Substrate Specificity | 3 | 0.0 |
20-Hydroxysteroid Dehydrogenases/genetics | 2 | 100.0 |
Biotransformation | 2 | 0.0 |
Kinetics | 4 | 0.0 |
Oxidation-Reduction | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Structure-Activity Relationship | 3 | 0.0 |
Aged | 4 | 0.0 |
Male | 6 | 0.0 |
Middle Aged | 5 | 0.0 |
3-Hydroxysteroid Dehydrogenases/genetics/metabolism | 2 | 40.0 |
Adult | 4 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Female | 8 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Cell Line | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Animals | 6 | 0.0 |
In Vitro | 3 | 0.0 |
Mice | 3 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
11-beta-Hydroxysteroid Dehydrogenase Type 1 | 2 | 100.0 |
Gene Expression | 2 | 0.0 |
Nitrosamines/*metabolism | 2 | 20.0 |
Binding Sites | 3 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Escherichia coli/genetics | 2 | 0.0 |
Liver/enzymology | 2 | 0.0 |
Rats | 2 | 0.0 |
Cytosol/*enzymology | 2 | 3.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Flufenamic Acid/pharmacology | 2 | 66.0 |
Models, Molecular | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Breast Neoplasms/*enzymology | 2 | 3.0 |
Progesterone/*metabolism | 3 | 8.0 |
Catalysis | 3 | 0.0 |
Molecular Sequence Data | 2 | 0.0 |
Ligands | 2 | 0.0 |
NADP/chemistry | 2 | 25.0 |
